Viatris gets global Minimised Risk of AMR Certification

Viatris announced that its Aurangabad, India, facility has received certification from the British Standards Institution (BSI) for meeting a new industry standard on Minimised Risk of Antimicrobial Resistance (AMR).
The standard was facilitated by BSI for the AMR Industry Alliance, an organisation made up of over 100 companies and associations from across the life-sciences industry with the shared goal of providing sustainable solutions to curb AMR. The certification is designed to encourage drug manufacturers and those in the supply chain to prioritise the sustainable production of antibiotics.
AMR is recognised around the world as a significant threat to global health and economic development and is a major driver of death globally. Recent research shows that in 2019, more than 1.2 million people are estimated to have died directly from antibiotic-resistant bacterial infections. By 2050, it is estimated that AMR will cause more deaths than cancer unless concerted efforts are undertaken to counter its progression.
Source: Expresspharma